Extended-Release Buprenorphine Treatments for Opioid Use Disorder

Event description
Sponsored by BSAS
Yes

Description

This training provides healthcare teams with information on the available extended-release injectable buprenorphine formulations for the treatment of opioid use disorder and how to implement them into clinical practice.

Topics include the pharmacology and side effects of extended-release injectable buprenorphine formulations; storage, administration, and patient selection processes; dosage, initiation, and maintenance for patients using weekly and monthly injectable doses; and the workflows and administrative tasks involved in implementing extended-release injectable buprenorphine in healthcare settings.

NOTE: This training is 60 minutes long. There will be an optional 30-minute Q&A session following the training, which will not count for credit.

Intended audience

Physicians, advanced practice providers, nurses, social workers, recovery coaches, and all other healthcare professionals treating addiction.

Details
Presenter
Andrea Jodat, DNP, FNP-BC, CARN-AP (she/her)
Jessica Kemp, RN, CARN
Event date
to
Attendance mode
Online
Address

United States

Cost
Free
Contact
Boston Medical Center Grayken Center for Addiction TTA
Organization
Boston Medical Center Grayken Center for Addiction TTA